Alphagan® P 0.1% : Patient

Frequently Asked Questions

What is ALPHAGAN^® P 0.1%?

Will ALPHAGAN^® P 0.1% cure my glaucoma?

How do I use ALPHAGAN^® P 0.1%?

What are the most common side effects of ALPHAGAN^® P 0.1%?

What can I do to manage my elevated IOP?

What is ALPHAGAN^® P 0.1%?
ALPHAGAN^® P 0.1% ophthalmic solution is an eye medication that's proven to lower elevated intraocular pressure (IOP). Elevated IOP is the only risk factor that may be treated to prevent glaucomatous vision loss.

Will ALPHAGAN^® P 0.1% cure my glaucoma?
No. There is no cure for glaucoma. But keeping your IOP low and under control by taking your eye medication as prescribed is one of the best things you can do to help protect your eyes from glaucomatous vision loss.

How do I use ALPHAGAN^® P 0.1%?
Take ALPHAGAN^® P 0.1% opthalmic solution exactly as your eye doctor prescribed. ALPHAGAN^® P 0.1% ophthalmic solution may be used with other topical drug products to lower IOP. If you are taking more than 1 eye medication, administer them at least 5 minutes apart.

What are the most common side effects of ALPHAGAN^® P 0.1%?
The most common side effects of ALPHAGAN^® P 0.1% are allergic conjunctivitis, eye redness (hyperemia), and itchy eyes.

What can I do to manage my elevated IOP?
The best thing you can do to manage your elevated IOP is to stay on your medication and take ALPHAGAN^® P 0.1% ophthalmic solution exactly as your eye care professional prescribed. You should talk to your eye care professional before you stop taking ALPHAGAN^® P 0.1%.

Indication: ALPHAGAN^® P 0.1% ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Important Safety Information
Contraindication: ALPHAGAN^® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy.
Precautions: Although ALPHAGAN^® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN^® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse events occurring in approximately 5% to 9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance.

Please click here for full product information.